Correlation Between SentinelOne and Hepion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both SentinelOne and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SentinelOne and Hepion Pharmaceuticals, you can compare the effects of market volatilities on SentinelOne and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and Hepion Pharmaceuticals.

Diversification Opportunities for SentinelOne and Hepion Pharmaceuticals

-0.22

Correlation Coefficient

SentinelOne  Hepion Pharmaceuticals

Very good diversification

The 3 months correlation between SentinelOne and Hepion is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of SentinelOne i.e., SentinelOne and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between SentinelOne and Hepion Pharmaceuticals

Taking into account the 90-day investment horizon SentinelOne is expected to generate 2.98 times less return on investment than Hepion Pharmaceuticals. But when comparing it to its historical volatility, SentinelOne is 3.56 times less risky than Hepion Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  57.00  in Hepion Pharmaceuticals on August 15, 2024 and sell it today you would earn a total of  6.00  from holding Hepion Pharmaceuticals or generate 10.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SentinelOne  vs.  Hepion Pharmaceuticals

SentinelOne

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SentinelOne are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, SentinelOne unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with SentinelOne and Hepion Pharmaceuticals

The main advantage of trading using opposite SentinelOne and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.

The idea behind SentinelOne and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..